Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses.docVIP

Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses

CirculatingBiomarkersforPredictingCardiovascular DiseaseRisk;aSystematicReviewandComprehensive OverviewofMeta-Analyses ThijsC.vanHolten1*,LeonieF.Waanders2,PhilipG.deGroot1,JoostVissers3,ImoE.Hoefer4, GerardPasterkamp4,MennoW.J.Prins2,MarkRoest1 1Laboratory for Clinical Chemistry and Hematology, UMC Utrecht, Utrecht, The Netherlands, 2Philips Research Laboratories, Philips, Eindhoven, The Netherlands, 3ResearchandDevelopment,FutureDiagnostics,Wijchen,TheNetherlands,4ExperimentalCardiologyDepartment,UMCUtrecht,Utrecht,TheNetherlands Abstract Background:Cardiovasculardiseaseisoneofthemajorcausesofdeathworldwide. Assessingtheriskforcardiovascular disease is an important aspect in clinical decision making and setting a therapeutic strategy, and the use of serological biomarkers may improve this. Despite an overwhelming number of studies and meta-analyses on biomarkers and cardiovasculardisease,therearenocomprehensivestudiescomparingtherelevanceofeachbiomarker.Weperformeda systematicreviewofmeta-analysesonlevelsofserologicalbiomarkersforatherothrombosistocomparetherelevanceof themostcommonlystudiedbiomarkers. MethodsandFindings:MedlineandEmbasewerescreenedonsearchtermsthatwererelatedto‘‘arterialischemicevents’’ and‘‘meta-analyses’’. Themeta-analysesweresortedby patientgroups withoutpre-existing cardiovascular disease,with cardiovasculardiseaseandheterogeneousgroupsconcerninggeneralpopulations,groupswithandwithoutcardiovascular disease, or miscellaneous. These were subsequently sorted by end-point for cardiovascular disease or stroke and summarized in tables. We have identified 85 relevant full text articles, with 214 meta-analyses. Markers for primary cardiovascular events include, from high to low result: C-reactive protein, fibrinogen, cholesterol, apolipoprotein B, the apolipoprotein A/apolipoprotein B ratio, high density lipoprotein, and vitamin D. Markers for secondary cardiovascular eventsinclude,fromhightolowresult:cardiactroponinsIandT,C-reactiveprotein

您可能关注的文档

文档评论(0)

118books + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档